(Q50881104)

English

Cross-sectional and longitudinal correlations between disease progression and different health-related quality of life domains in persons with amyotrophic lateral sclerosis.

scientific article published in December 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Cross-sectional and longitudinal correlations between disease progression and different health-related quality of life domains in persons with amyotrophic lateral sclerosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

amyotrophic lateral sclerosis

0 references

quality of life

1 reference

based on heuristic

inferred from title

author name string

Imelda J M De Groot

1

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Marcel W M Post

2

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Tineke van Heuveln

3

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Leonard H Van den Berg

4

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Eline Lindeman

5

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

publication date

1 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

8

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

6

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

356-361

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Multidisciplinary ALS care improves quality of life in patients with ALS.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Factors supporting quality of life over time for individuals with amyotrophic lateral sclerosis: the role of positive self-perception and religiosity.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

A cross sectional study on determinants of quality of life in ALS.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Quality of Life in Patients with Amyotrophic Lateral Sclerosis: Perceptions, Coping Resources, and Illness Characteristics

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Validation of quality of life instruments in ALS.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Quality of life in ALS depends on factors other than strength and physical function.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Patients' assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Comparison of instruments addressing quality of life in patients with ALS and their caregivers.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Measures and markers in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Effects of the early diagnosis of amyotrophic lateral sclerosis on the patient: disadvantages.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Clinical and epidemiological features of motor neuron disease in south-western Greece

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

A randomized sequential trial of creatine in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Resilience and distress among amyotrophic lateral sclerosis patients and caregivers

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Prevalence of depressive disorders and change over time in late-stage ALS.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Emotional responding in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Amyotrophic lateral sclerosis and hopelessness: psychosocial factors

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Measuring quality of life: Is quality of life determined by expectations or experience?

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Longitudinal quality of life in advanced cancer patients: pilot study results from a VA medical cancer center.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Patients' health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Inter-evaluator reliability of the ALS Functional Rating Scale

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Identifiers

10.1080/17482960701553949

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50881104&oldid=1241972049"